Target Price | $14.50 |
Price | $2.19 |
Potential |
562.10%
register free of charge
|
Number of Estimates | 6 |
6 Analysts have issued a price target Black Diamond Therapeutics Inc 2025 .
The average Black Diamond Therapeutics Inc target price is $14.50.
This is
562.10%
register free of charge
$20.00
813.24%
register free of charge
$9.00
310.96%
register free of charge
|
|
A rating was issued by 7 analysts: 7 Analysts recommend Black Diamond Therapeutics Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Black Diamond Therapeutics Inc stock has an average upside potential 2025 of
562.10%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.88 | -1.30 |
25.10% | 30.85% | |
P/E | negative |
7 Analysts have issued a Black Diamond Therapeutics Inc forecast for earnings per share. The average Black Diamond Therapeutics Inc <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Black Diamond Therapeutics Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.